Evidence map›Paper›PMID 27229762›Full record

ArticleOncotarget2016

Genetic scores based on risk-associated single nucleotide polymorphisms (SNPs) can reveal inherited risk of renal cell carcinoma.

Yishuo Wu, Ning Zhang, Kaiwen Li, Haitao Chen, Xiaolin Lin, Yang Yu, Yuancheng Gou, Jiangang Hou, Deke Jiang, Rong Na and 3 more

Abstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Validation ofFrontiers in medicine · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. miR-199b-5p serves as a tumor suppressor in renal cell carcinoma.Experimental and therapeutic medicine · 2018
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yishuo WuDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, PR China.
Ning ZhangDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, PR China.
Kaiwen LiDepartment of Urology, Sun Yat-sen Memorial Hospital, Sun Yet-sen University, Guangdong, PR China.
Haitao ChenState Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, PR China.
Xiaolin LinFudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, PR China.
Yang YuDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, PR China.
Yuancheng GouDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, PR China.
Jiangang HouDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, PR China.
Deke JiangState Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, PR China.
Rong NaDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, PR China.
Xiang WangDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, PR China.
Qiang DingDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, PR China.
Jianfeng XuFudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to evaluate whether renal cell carcinoma (RCC) risk-associated single nucleotide polymorphisms (SNPs) could reflect the individual inherited risks of RCC. A total of 346 RCC patients and 1,130 controls were recruited in this case-control study. Genetic scores were calculated for each individual based on the odds ratios and frequencies of risk-associated SNPs. Four SNPs were significantly associated with RCC in Chinese population. Two genetic score models were established, genetic score 1 (rs10054504, rs7023329 and rs718314) and genetic score 2 (rs10054504, rs7023329 and rs1049380). For genetic score 1, the individual likelihood of RCC with low (<0.8), medium (0.8-1.2) and high (≥1.2) genetic score 1 was 15.61%, 22.25% and 33.92% respectively (P-trend=6.88×10(-7)). For genetic score 2, individual with low (<0.8), medium (0.8-1.2) and high (≥1.2) genetic score 2 would have likelihood of RCC as 14.39%, 24.54% and 36.48%, respectively (P-trend=1.27×10(-10)). The area under the receiver operating curve (AUC) of genetic score 1 was 0.626, and AUC of genetic score 2 was 0.658. We concluded that genetic score can reveal personal risk and inherited risk of RCC, especially when family history is not available.

Indexed as

Carcinoma, Renal CellCase-Control StudiesFemaleGenetic Predisposition to DiseaseHumansKidney NeoplasmsMaleMiddle AgedPolymorphism, Single NucleotideRisk FactorsChinesegenetic scorerenal cell carcinomaSNPs

Identifiers

PMID27229762
PMCPMC4951315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.